The Agency, based on the opinion of the Committee for Medicinal Products for Veterinary Use, has recommended the establishment of an MRL for imidacloprid in Salmonidae, applicable to muscle and skin in natural proportions.
Recital 5, Regulation (EU) 2021/621
In force